About Kryptos Biotechnologies
Kryptos Biotechnologies is a company based in Hayward (United States) founded in 2017 by Jinyong Lee and Jun Ho Son.. Kryptos Biotechnologies has raised $12.7 million across 3 funding rounds from investors including HHS, OSANG Healthcare and FuturePlay. Kryptos Biotechnologies offers products and services including Infectious Disease Diagnostics and Life Science Solutions. Kryptos Biotechnologies operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and NeuMoDx, among others.
- Headquarter Hayward, United States
- Founders Jinyong Lee, Jun Ho Son
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Kryptos Biotechnologies, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.7 M (USD)
in 3 rounds
-
Latest Funding Round
$10 M (USD), Series A
Mar 28, 2024
-
Investors
HHS
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kryptos Biotechnologies
Kryptos Biotechnologies offers a comprehensive portfolio of products and services, including Infectious Disease Diagnostics and Life Science Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers PCR-based testing for point-of-care infectious disease detection.
Provides innovative analytical systems for healthcare and scientific applications.
Unlock access to complete
Unlock access to complete
Funding Insights of Kryptos Biotechnologies
Kryptos Biotechnologies has successfully raised a total of $12.7M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $10.0M
-
First Round
First Round
(27 Sep 2017)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Series A - Kryptos Biotechnologies | Valuation | OSANG Healthcare |
|
| Nov, 2019 | Amount | Seed - Kryptos Biotechnologies | Valuation | FuturePlay , Coolidge Corner Investment |
|
| Sep, 2017 | Amount | Grant - Kryptos Biotechnologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kryptos Biotechnologies
Kryptos Biotechnologies has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, OSANG Healthcare and FuturePlay. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
FuturePlay is engaged in startup investment and acceleration.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Offers financial services including auto loans, corporate finance, and investments to customers.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kryptos Biotechnologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Kryptos Biotechnologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kryptos Biotechnologies Comparisons
Competitors of Kryptos Biotechnologies
Kryptos Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and NeuMoDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a platform for low cost molecular testing
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kryptos Biotechnologies
Frequently Asked Questions about Kryptos Biotechnologies
When was Kryptos Biotechnologies founded?
Kryptos Biotechnologies was founded in 2017.
Where is Kryptos Biotechnologies located?
Kryptos Biotechnologies is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Who is the current CEO of Kryptos Biotechnologies?
Jun Ho Son is the current CEO of Kryptos Biotechnologies. They have also founded this company.
Is Kryptos Biotechnologies a funded company?
Kryptos Biotechnologies is a funded company, having raised a total of $12.7M across 3 funding rounds to date. The company's 1st funding round was a Grant of $198.29K, raised on Sep 27, 2017.
What does Kryptos Biotechnologies do?
Kryptos Biotechnologies was founded in 2017 and is based in Hayward, United States. Operations focus on the biotechnology sector, where a point-of-care molecular diagnostic platform is developed and provided. The platform relies on Ultrafast Photonic PCR, which employs photothermal heating through plasmonic thin films driven by light-emitting diodes. Applications include diagnostics for infectious diseases, cardiac conditions, cancer, neurological disorders, and biowarfare pathogen detection at the point-of-care.
Who are the top competitors of Kryptos Biotechnologies?
Kryptos Biotechnologies's top competitors include Visby Medical, Inflammatix and MeMed.
What products or services does Kryptos Biotechnologies offer?
Kryptos Biotechnologies offers Infectious Disease Diagnostics and Life Science Solutions.
Who are Kryptos Biotechnologies's investors?
Kryptos Biotechnologies has 5 investors. Key investors include HHS, OSANG Healthcare, FuturePlay, Coolidge Corner Investment, and KBD Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.